PDB Short entry for 1W6J HEADER ISOMERASE 18-AUG-04 1W6J TITLE STRUCTURE OF HUMAN OSC IN COMPLEX WITH RO 48-8071 COMPND MOL_ID: 1; COMPND 2 MOLECULE: LANOSTEROL SYNTHASE; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: OXIDOSQUALENE--LANOSTEROL CYCLASE, OXIDO SQUALENE CYCLASE, COMPND 5 2,3-EPOXYSQUALENE--LANOSTEROL CYCLASE, OSC; COMPND 6 EC: 5.4.99.7; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: PICHIA PASTORIS; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 4922; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: GS115; SOURCE 8 EXPRESSION_SYSTEM_PLASMID: PPICZB KEYWDS CYCLASE, CHOLESTEROL, LANOSTEROL, MONOTOPIC MEMBRANE PROTEIN, B- KEYWDS 2 OCTYL-GLUCOSIDE, ISOMERASE, STEROID BIOSYNTHESIS EXPDTA X-RAY DIFFRACTION AUTHOR R.THOMA,T.SCHULZ-GASCH,B.D'ARCY,J.BENZ,J.AEBI,H.DEHMLOW,M.HENNIG, AUTHOR 2 A.RUF REVDAT 5 13-DEC-23 1W6J 1 HETSYN REVDAT 4 29-JUL-20 1W6J 1 COMPND REMARK HETNAM SITE REVDAT 3 20-NOV-13 1W6J 1 REMARK VERSN HETSYN FORMUL REVDAT 2 24-FEB-09 1W6J 1 VERSN REVDAT 1 29-OCT-04 1W6J 0 JRNL AUTH R.THOMA,T.SCHULZ-GASCH,B.D'ARCY,J.BENZ,J.AEBI,H.DEHMLOW, JRNL AUTH 2 M.HENNIG,M.STIHLE,A.RUF JRNL TITL INSIGHT INTO STEROID SCAFFOLD FORMATION FROM THE STRUCTURE JRNL TITL 2 OF HUMAN OXIDOSQUALENE CYCLASE JRNL REF NATURE V. 432 118 2004 JRNL REFN ISSN 0028-0836 JRNL PMID 15525992 JRNL DOI 10.1038/NATURE02993 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH A.RUF,F.MULLER,B.D'ARCY,M.STIHLE,E.KUZNIR,C.HANDSCHIN, REMARK 1 AUTH 2 O.MORAND,R.THOMA REMARK 1 TITL THE MONOTOPIC MEMBRANE PROTEIN HUMAN OSC IS ACTIVE AS REMARK 1 TITL 2 MONOMER REMARK 1 REF BIOCHEM.BIOPHYS.RES.COMMUN. V. 315 247 2004 REMARK 1 REFN ISSN 0006-291X REMARK 1 PMID 14766201 REMARK 1 DOI 10.1016/J.BBRC.2004.01.052 REMARK 2 REMARK 2 RESOLUTION. 2.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.1.9999 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 141.42 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 97.7 REMARK 3 NUMBER OF REFLECTIONS : 56956 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.171 REMARK 3 R VALUE (WORKING SET) : 0.170 REMARK 3 FREE R VALUE : 0.199 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 3033 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.20 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.26 REMARK 3 REFLECTION IN BIN (WORKING SET) : 3984 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.2300 REMARK 3 BIN FREE R VALUE SET COUNT : 194 REMARK 3 BIN FREE R VALUE : 0.2880 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5824 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 90 REMARK 3 SOLVENT ATOMS : 416 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 36.08 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 1.69000 REMARK 3 B22 (A**2) : -2.79000 REMARK 3 B33 (A**2) : 1.10000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.172 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.150 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.102 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 4.020 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.964 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.950 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 6081 ; 0.009 ; 0.021 REMARK 3 BOND LENGTHS OTHERS (A): 5402 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 8246 ; 1.180 ; 1.937 REMARK 3 BOND ANGLES OTHERS (DEGREES): 12520 ; 0.831 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 725 ; 5.261 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 296 ;33.632 ;22.905 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 949 ;14.608 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 50 ;12.345 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 852 ; 0.071 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 6784 ; 0.004 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 1341 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 1304 ; 0.205 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): 5412 ; 0.184 ; 0.200 REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): 3128 ; 0.083 ; 0.200 REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 381 ; 0.142 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 17 ; 0.152 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): 57 ; 0.273 ; 0.200 REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 6 ; 0.241 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 3704 ; 0.645 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 5779 ; 1.015 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 2776 ; 1.390 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 2467 ; 2.219 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. REMARK 4 REMARK 4 1W6J COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 18-AUG-04. REMARK 100 THE DEPOSITION ID IS D_1290020817. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 03-MAR-02 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X06SA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.92004 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 60002 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.200 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.0 REMARK 200 DATA REDUNDANCY : 3.000 REMARK 200 R MERGE (I) : 0.10000 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 7.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.26 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.5 REMARK 200 DATA REDUNDANCY IN SHELL : 3.00 REMARK 200 R MERGE FOR SHELL (I) : 0.38000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.500 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: PDB ENTRY 2SQC REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 65.92 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.61 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 25% (W/V) PEG3350 0.4M AMMONIUM REMARK 280 ACETATE 0.1M TRIS PH 8.5 10% (V/V) ETHYLENE GLYCOL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 2 2 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -X,Y,-Z+1/2 REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 31.31900 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 31.31900 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 94.95750 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 101.21200 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 94.95750 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 101.21200 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 31.31900 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 94.95750 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 101.21200 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 31.31900 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 94.95750 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 101.21200 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 CATALYZES THE CYCLIZATION OF (S)-2,3 OXIDOSQUALENE TO REMARK 400 LANOSTEROL, A REACTION THAT FORMS THE STEROL NUCLEUS. REMARK 400 BELONGS TO THE TERPENE CYCLASE/MUTASE FAMILY. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 THR A 2 REMARK 465 GLU A 3 REMARK 465 GLY A 4 REMARK 465 THR A 5 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 42 CB CG CD OE1 OE2 REMARK 470 ARG A 43 CB CG CD NE CZ NH1 NH2 REMARK 470 ALA A 44 CB REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH A 2125 O HOH A 2327 1.92 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ASP A 41 CB - CG - OD2 ANGL. DEV. = 5.9 DEGREES REMARK 500 ASP A 97 CB - CG - OD2 ANGL. DEV. = 6.7 DEGREES REMARK 500 ASP A 283 CB - CG - OD2 ANGL. DEV. = 5.8 DEGREES REMARK 500 ASP A 523 CB - CG - OD2 ANGL. DEV. = 5.5 DEGREES REMARK 500 ARG A 604 NE - CZ - NH2 ANGL. DEV. = -3.2 DEGREES REMARK 500 ASP A 605 CB - CG - OD2 ANGL. DEV. = 5.6 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU A 42 -72.76 76.44 REMARK 500 ARG A 43 65.40 -69.43 REMARK 500 ALA A 44 83.20 160.12 REMARK 500 PHE A 212 65.68 39.09 REMARK 500 SER A 334 -164.14 59.10 REMARK 500 SER A 445 -86.22 -104.44 REMARK 500 THR A 502 -85.15 -96.52 REMARK 500 GLU A 504 -136.58 -141.43 REMARK 500 GLU A 519 -40.60 73.46 REMARK 500 CYS A 584 -71.36 -144.40 REMARK 500 GLU A 690 -138.16 -122.02 REMARK 500 LYS A 698 -32.48 75.15 REMARK 500 REMARK 500 REMARK: NULL REMARK 600 REMARK 600 HETEROGEN REMARK 600 REMARK 600 (C14) UNIDENTIFIED LIPID FRAGMENT, MODELLED AS LINEAR CARBON CHAIN REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 BOG A 1737 DBREF 1W6J A 1 732 UNP P48449 ERG7_HUMAN 1 732 SEQRES 1 A 732 MET THR GLU GLY THR CYS LEU ARG ARG ARG GLY GLY PRO SEQRES 2 A 732 TYR LYS THR GLU PRO ALA THR ASP LEU GLY ARG TRP ARG SEQRES 3 A 732 LEU ASN CYS GLU ARG GLY ARG GLN THR TRP THR TYR LEU SEQRES 4 A 732 GLN ASP GLU ARG ALA GLY ARG GLU GLN THR GLY LEU GLU SEQRES 5 A 732 ALA TYR ALA LEU GLY LEU ASP THR LYS ASN TYR PHE LYS SEQRES 6 A 732 ASP LEU PRO LYS ALA HIS THR ALA PHE GLU GLY ALA LEU SEQRES 7 A 732 ASN GLY MET THR PHE TYR VAL GLY LEU GLN ALA GLU ASP SEQRES 8 A 732 GLY HIS TRP THR GLY ASP TYR GLY GLY PRO LEU PHE LEU SEQRES 9 A 732 LEU PRO GLY LEU LEU ILE THR CYS HIS VAL ALA ARG ILE SEQRES 10 A 732 PRO LEU PRO ALA GLY TYR ARG GLU GLU ILE VAL ARG TYR SEQRES 11 A 732 LEU ARG SER VAL GLN LEU PRO ASP GLY GLY TRP GLY LEU SEQRES 12 A 732 HIS ILE GLU ASP LYS SER THR VAL PHE GLY THR ALA LEU SEQRES 13 A 732 ASN TYR VAL SER LEU ARG ILE LEU GLY VAL GLY PRO ASP SEQRES 14 A 732 ASP PRO ASP LEU VAL ARG ALA ARG ASN ILE LEU HIS LYS SEQRES 15 A 732 LYS GLY GLY ALA VAL ALA ILE PRO SER TRP GLY LYS PHE SEQRES 16 A 732 TRP LEU ALA VAL LEU ASN VAL TYR SER TRP GLU GLY LEU SEQRES 17 A 732 ASN THR LEU PHE PRO GLU MET TRP LEU PHE PRO ASP TRP SEQRES 18 A 732 ALA PRO ALA HIS PRO SER THR LEU TRP CYS HIS CYS ARG SEQRES 19 A 732 GLN VAL TYR LEU PRO MET SER TYR CYS TYR ALA VAL ARG SEQRES 20 A 732 LEU SER ALA ALA GLU ASP PRO LEU VAL GLN SER LEU ARG SEQRES 21 A 732 GLN GLU LEU TYR VAL GLU ASP PHE ALA SER ILE ASP TRP SEQRES 22 A 732 LEU ALA GLN ARG ASN ASN VAL ALA PRO ASP GLU LEU TYR SEQRES 23 A 732 THR PRO HIS SER TRP LEU LEU ARG VAL VAL TYR ALA LEU SEQRES 24 A 732 LEU ASN LEU TYR GLU HIS HIS HIS SER ALA HIS LEU ARG SEQRES 25 A 732 GLN ARG ALA VAL GLN LYS LEU TYR GLU HIS ILE VAL ALA SEQRES 26 A 732 ASP ASP ARG PHE THR LYS SER ILE SER ILE GLY PRO ILE SEQRES 27 A 732 SER LYS THR ILE ASN MET LEU VAL ARG TRP TYR VAL ASP SEQRES 28 A 732 GLY PRO ALA SER THR ALA PHE GLN GLU HIS VAL SER ARG SEQRES 29 A 732 ILE PRO ASP TYR LEU TRP MET GLY LEU ASP GLY MET LYS SEQRES 30 A 732 MET GLN GLY THR ASN GLY SER GLN ILE TRP ASP THR ALA SEQRES 31 A 732 PHE ALA ILE GLN ALA LEU LEU GLU ALA GLY GLY HIS HIS SEQRES 32 A 732 ARG PRO GLU PHE SER SER CYS LEU GLN LYS ALA HIS GLU SEQRES 33 A 732 PHE LEU ARG LEU SER GLN VAL PRO ASP ASN PRO PRO ASP SEQRES 34 A 732 TYR GLN LYS TYR TYR ARG GLN MET ARG LYS GLY GLY PHE SEQRES 35 A 732 SER PHE SER THR LEU ASP CYS GLY TRP ILE VAL SER ASP SEQRES 36 A 732 CYS THR ALA GLU ALA LEU LYS ALA VAL LEU LEU LEU GLN SEQRES 37 A 732 GLU LYS CYS PRO HIS VAL THR GLU HIS ILE PRO ARG GLU SEQRES 38 A 732 ARG LEU CYS ASP ALA VAL ALA VAL LEU LEU ASN MET ARG SEQRES 39 A 732 ASN PRO ASP GLY GLY PHE ALA THR TYR GLU THR LYS ARG SEQRES 40 A 732 GLY GLY HIS LEU LEU GLU LEU LEU ASN PRO SER GLU VAL SEQRES 41 A 732 PHE GLY ASP ILE MET ILE ASP TYR THR TYR VAL GLU CYS SEQRES 42 A 732 THR SER ALA VAL MET GLN ALA LEU LYS TYR PHE HIS LYS SEQRES 43 A 732 ARG PHE PRO GLU HIS ARG ALA ALA GLU ILE ARG GLU THR SEQRES 44 A 732 LEU THR GLN GLY LEU GLU PHE CYS ARG ARG GLN GLN ARG SEQRES 45 A 732 ALA ASP GLY SER TRP GLU GLY SER TRP GLY VAL CYS PHE SEQRES 46 A 732 THR TYR GLY THR TRP PHE GLY LEU GLU ALA PHE ALA CYS SEQRES 47 A 732 MET GLY GLN THR TYR ARG ASP GLY THR ALA CYS ALA GLU SEQRES 48 A 732 VAL SER ARG ALA CYS ASP PHE LEU LEU SER ARG GLN MET SEQRES 49 A 732 ALA ASP GLY GLY TRP GLY GLU ASP PHE GLU SER CYS GLU SEQRES 50 A 732 GLU ARG ARG TYR LEU GLN SER ALA GLN SER GLN ILE HIS SEQRES 51 A 732 ASN THR CYS TRP ALA MET MET GLY LEU MET ALA VAL ARG SEQRES 52 A 732 HIS PRO ASP ILE GLU ALA GLN GLU ARG GLY VAL ARG CYS SEQRES 53 A 732 LEU LEU GLU LYS GLN LEU PRO ASN GLY ASP TRP PRO GLN SEQRES 54 A 732 GLU ASN ILE ALA GLY VAL PHE ASN LYS SER CYS ALA ILE SEQRES 55 A 732 SER TYR THR SER TYR ARG ASN ILE PHE PRO ILE TRP ALA SEQRES 56 A 732 LEU GLY ARG PHE SER GLN LEU TYR PRO GLU ARG ALA LEU SEQRES 57 A 732 ALA GLY HIS PRO HET R71 A1733 28 HET BOG A1734 20 HET C14 A1735 14 HET BOG A1736 20 HET BOG A1737 8 HETNAM R71 [4-({6-[ALLYL(METHYL)AMINO]HEXYL}OXY)-2- HETNAM 2 R71 FLUOROPHENYL](4-BROMOPHENYL)METHANONE HETNAM BOG OCTYL BETA-D-GLUCOPYRANOSIDE HETNAM C14 TETRADECANE HETSYN R71 RO 48-8071 HETSYN BOG BETA-OCTYLGLUCOSIDE; OCTYL BETA-D-GLUCOSIDE; OCTYL D- HETSYN 2 BOG GLUCOSIDE; OCTYL GLUCOSIDE FORMUL 2 R71 C23 H27 BR F N O2 FORMUL 3 BOG 3(C14 H28 O6) FORMUL 4 C14 C14 H30 FORMUL 7 HOH *416(H2 O) HELIX 1 1 ASP A 21 GLY A 23 5 3 HELIX 2 2 THR A 49 GLY A 57 1 9 HELIX 3 3 THR A 72 GLY A 86 1 15 HELIX 4 4 PHE A 103 ALA A 115 1 13 HELIX 5 5 GLY A 122 GLN A 135 1 14 HELIX 6 6 THR A 150 LEU A 164 1 15 HELIX 7 7 ASP A 170 LYS A 183 1 14 HELIX 8 8 GLY A 185 ILE A 189 5 5 HELIX 9 9 PRO A 190 LEU A 200 1 11 HELIX 10 10 SER A 204 LEU A 208 5 5 HELIX 11 11 PHE A 212 PHE A 218 5 7 HELIX 12 12 HIS A 225 LEU A 229 5 5 HELIX 13 13 TRP A 230 VAL A 246 1 17 HELIX 14 14 ASP A 253 LEU A 263 1 11 HELIX 15 15 ASP A 267 ILE A 271 5 5 HELIX 16 16 ASP A 272 ARG A 277 5 6 HELIX 17 17 ALA A 281 LEU A 285 5 5 HELIX 18 18 SER A 290 HIS A 306 1 17 HELIX 19 19 SER A 308 LYS A 331 1 24 HELIX 20 20 GLY A 336 GLY A 352 1 17 HELIX 21 21 SER A 355 ARG A 364 1 10 HELIX 22 22 ILE A 365 ASP A 367 5 3 HELIX 23 23 SER A 384 ALA A 399 1 16 HELIX 24 24 GLY A 400 ARG A 404 5 5 HELIX 25 25 ARG A 404 GLU A 406 5 3 HELIX 26 26 PHE A 407 GLN A 422 1 16 HELIX 27 27 ASP A 429 TYR A 434 5 6 HELIX 28 28 VAL A 453 CYS A 471 1 19 HELIX 29 29 PRO A 479 ASN A 492 1 14 HELIX 30 30 GLY A 509 ASN A 516 5 8 HELIX 31 31 TYR A 530 PHE A 548 1 19 HELIX 32 32 ARG A 552 GLN A 571 1 20 HELIX 33 33 CYS A 584 MET A 599 1 16 HELIX 34 34 CYS A 609 SER A 621 1 13 HELIX 35 35 PHE A 633 ARG A 639 1 7 HELIX 36 36 GLN A 648 VAL A 662 1 15 HELIX 37 37 ASP A 666 GLN A 681 1 16 HELIX 38 38 SER A 706 TYR A 723 1 18 HELIX 39 39 ARG A 726 GLY A 730 5 5 SHEET 1 AA 2 TRP A 25 GLU A 30 0 SHEET 2 AA 2 ARG A 33 TYR A 38 -1 O ARG A 33 N GLU A 30 SHEET 1 AB 2 LEU A 369 GLY A 372 0 SHEET 2 AB 2 GLY A 375 MET A 378 -1 O GLY A 375 N GLY A 372 SHEET 1 AC 2 GLY A 694 PHE A 696 0 SHEET 2 AC 2 CYS A 700 ILE A 702 -1 O CYS A 700 N PHE A 696 CISPEP 1 GLY A 12 PRO A 13 0 -11.73 CISPEP 2 VAL A 583 CYS A 584 0 -14.08 CRYST1 189.915 202.424 62.638 90.00 90.00 90.00 C 2 2 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.005266 0.000000 0.000000 0.00000 SCALE2 0.000000 0.004940 0.000000 0.00000 SCALE3 0.000000 0.000000 0.015965 0.00000